Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par spéciliste : Prof Frederic Rouillon

Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier (France) MAJ Il y a 4 ans

A study to determine the maintenance of efficacy of agomelatine to prevent relapse in out-patients with major depressive disorder. A 8 to 10 weeks open period treatment with agomelatine followed by 24 weeks randomised double-blind period, placebo-controlled, parallel groups and 20 weeks of optional double-blind treatment period Not provided at time of registration and not expected to be available in the future

Pays Australia, Finland, France, South Africa, United Kingdom
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations